XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Deficit) and Employee Incentive Plans (Tables)
 3 Months Ended
Apr. 30, 2022
Equity And Compensation Related Costs Share Based Payments [Abstract]  
Schedule of Reserved Common Stock for Future Issuance
As of April 30, 2022, the Company has reserved common stock for future issuance as follows:
Number of Shares
Stock options outstanding8,603,980 
Restricted stock units issued and outstanding3,956,641 
Remaining shares available for issuance under the 2021 Plan2,643,474 
ESPP1,030,975 
Common stock warrants105,350 
Total16,340,420 
Schedule of Stock Option Activity under Stock Plans
The following table summarizes stock option activity under the Stock Plans for the three months ended April 30, 2022 (aggregate intrinsic value in thousands):
Options OutstandingWeighted-
Average
Contractual
Term		Aggregate
Intrinsic
Value
Number of
Options		Weighted-
Average
Exercise
Price
Balances as of January 31, 2022
9,150,821 $9.76 6.53$126,368 
Options exercised(435,639)$5.79 
Options granted— $— 
Options cancelled(111,202)$14.54 
Balances as of April 30, 2022
8,603,980 $9.90 6.46$70,965 
Options vested and expected to vest as of April 30, 2022
8,603,980 $9.90 6.46$70,965 
Options vested and exercisable as of April 30, 2022
6,063,428 $7.50 5.65$60,069 
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity
The following table is a summary of RSU activity for the three months ended April 30, 2022:
RSUs Outstanding
Number of RSUs Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022
283,558 $43.76 
RSUs granted2,512,511 19.79 
RSUs vested— — 
RSUs forfeited(53,428)26.65 
Balances as of April 30, 2022
2,742,641 $22.13 
Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:
January 31, 2022
Expected term (in years)5.0
Volatility50.0 %
Risk-free interest rate1.7 %
Dividend yield— 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of employee stock options was estimated using the following weighted-average assumptions:
Three Months Ended April 30,
20222021
Stock Option Plans:
Expected term (in years)*6.1
Expected volatility*41.9 %
Risk-free interest rate*1.0 %
Dividend yield*— 
*No stock options were granted during the three months ended April 30, 2022.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of employee stock purchase rights for the initial offering period under the 2021 ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Three Months Ended April 30, 2022
Employee Stock Purchase Plan:
Expected term (in years)
1.1 - 2.1
Expected volatility
46.7% - 52.1%
Risk-free interest rate
0.1% - 0.2%
Dividend yield—
Schedule of Stock-Based Compensation Expense
Stock-Based Compensation
Stock-based compensation expense was as follows (in thousands):
Three Months Ended April 30,
20222021
Cost of revenue—subscription$122 $27 
Cost of revenue—services94 22 
Research and development1,899 570 
Sales and marketing1,987 541 
General and administrative1,348 669 
Total stock-based compensation expense$5,450 $1,829